Atopic eczema: Genetics or environment?

Annals of Agricultural and Environmental Medicine

Volumn 14, Issue 2, 2007, Pages 195-201

  Wüthrich, Brunello ^a,b   Cozzio, Antonio ^b   Roll, Antonie ^b   Senti, Gabriela ^b   Kündig, Thomas ^b   Schmid Grendelmeier, Peter ^b  

^a Spital Zollikerberg ^*  (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Atopic eczema; Atopy march; Atopy patch tests; Filaggrin; Food; Genetic; IgE associated; Inhalants; Malassezia sympodialis; Non IgE associated; Nonatopic eczema; Oral food challenges; Silk textiles; Skin barrier; Staphylococcus aureus; Subtypes; Superantigens

Indexed keywords

BACTERIAL TOXIN; CHEMOKINE; CORTICOSTEROID; CYTOKINE; EMOLLIENT AGENT; ENTEROTOXIN; FILAGGRIN; FUSIDIC ACID; IMMUNOGLOBULIN E; ITRACONAZOLE; PIMECROLIMUS; PLACEBO; SUPERANTIGEN; TACROLIMUS;

ATOPIC DERMATITIS; BACTERIAL COLONIZATION; CLINICAL TRIAL; CONFERENCE PAPER; CYTOSKELETON; DENDRITIC CELL; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; EOSINOPHIL; FLG GENE; GENE; GENE MUTATION; GENETIC RISK; HOMOZYGOTE; HUMAN; INFLAMMATION; KERATINOCYTE; MACROPHAGE; MALASSEZIA; MAST CELL; MYCOSIS; PHENOTYPE; PROGNOSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

DERMATITIS, ATOPIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOSUPPRESSIVE AGENTS; INTERMEDIATE FILAMENT PROTEINS; MUTATION; PHENOTYPE; TACROLIMUS;

MALASSEZIA; MALASSEZIA SYMPODIALIS; STAPHYLOCOCCUS AUREUS;

EID: 39649083624     PISSN: 12321966     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (55)

1. Äberg N, Engstrom I: Natural history of allergic disease in children. Acta Paediat Scand 1990, 79, 206-211.
2. Akdis CA, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P, Hamid Q, Kapp A, Leung DYM, Lipozencic J, Luger TA, Muraro A, Novak N, Platts-Mills TAE, Rosenwasser L, Scheynius A, Simons FER, Spergel J, Turjanmaa K, Wahn U, Weidinger S, Werfel T, Zuberbier T for the European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Group: Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Immunology/PRACTALL Consensus Report. Allergy 2006, 61, 969-987.
3. Akiyama H, Hamada T, Huh WK, Yamasaki O, Oono T, Fujimoto W, Iwatsuki K: Confocal laser scanning microscopic observation of glycocalyx production by Staphylococcus aureus in skin lesions of bullous impetigo, atopic dermatitis and pemphigus foliaceus. Br J Dermatol 2003, 148, 526-532.
4. Boguniewicz M, Leung DYM: Atopic dermatitis. J Allergy Clin Immunol 2006, 117(Suppl), S475-480.
5. Boguniewicz M, Schmid-Grendelmeier P, Leung DYM: Atopic dermatitis. J Allergy Clin Immunol 2006, 118, 40-43.
6. Cookson WO, Moffatt, MF: The genetics of atopic dermatitis. Curr Opin Allergy Clin Immunol 2002, 2, 383-387.
7. Darsow J. Laifaoui U, Kerschenlohr K, Wollenberg A, Przybilla U, Wüthrich B, Borelli Jr S, Giusti F, Seidenari S, Drzimalla K, Simon, Oranje AP, De Raeve L, Taieb A, Bolhaar S, Bruijnzeel-Koomen C, Brönnimann M, Braathen LR, Didierlaurent A, André C, Ring J: The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study. Allergy 2004, 59, 1318-1325.
8. Elliot K, Forrest S: Genetics of atopic dermatitis. In: Bieber Th, Leung DYM (Eds): Impact of Atopic Dermatitis, 81-110. Marcel Dekker, New York-Basel 2002.
9. ETAC Study Group: Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomized, placebo-controlled trial: first results of ETAC. Pediatr Allergy Immunol 1998, 9, 116-124.
10. Fischer B, Tengvall-Linder M, Flückiger S, Johansson C, Blaser K, Scheynius A, Wüthrich B, Crameri R, Schmid-Grendelmeier P: Malassezia sympodialis als krankheitsspezifisches Allergen bei der atopischen Dermatitis. Allergologie 2003, 26, 509-515.
11. Fölster-Holst R, Pape M, Buss YL, Christophers E, Weichenthal M: Low prevalence of the intrinsic form of atopic dermatitis among adult patients. Allergy 2006, 61, 629-632.
12. Grize L, Gassner M, Wüthrich B, Bringolf-Isler B, Takken-Sahl K, Sennhauser FH, Stricker T, Eigenmann PA, Braun-Fahrländer C, on behalf of the Swiss Surveillance Programme on Childood Allergy and Respiratory symptoms with respect to Air Pollution (SCARPOL): Trends in prevalence of asthma, allergic rhinitis and atopic dermatitis in 5-7 year old Swiss children from 1992 to 2001. Allergy 2006, 61, 556-562.
13. Hauser C, Wüthrich B, Matter L, Wilhelm JA, Sonnabend W, Schopfer K: Staphylococcus aureus skin colonization in atopic dermatitis patients. Dermatologica 1985, 170, 35-39.
14. Hauser C, Wüthrich B, Matter L, Wilhelm JA, Schopfer K: Immune response to Staphylococcus aureus in atopic dermatitis. Dermatologica 1985, 170, 114-120.
15. Hauser C, Wüthrich B, Matter L, Wilhelm JA, Schopfer K: The Immune response to S. aureus in atopic dermatitis. Acta Derm Venereol (Stockh) 1985, Suppl. 114, 101-104.
16. Heine G, Schnuch A, Uter W, Worm M; Information Network of Departments of Dermatology (IVDK); German Contact Dermatitis Research Group (DKG): Type-IV sensitization profile of individuals with atopic eczema: results from the Information Network of Departments of Dermatology (IVDK) and the German Contact Dermatitis Research Group (DKG). Allergy 2006, 61, 611-616.
17. Hudson TJ: Skin barrier function and allergic risk. Nat Genet 2006, 38, 399-400.
18. Hultsch T, Kapp A, Spergel J: Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Dermatology 2005, 211, 174-187.
19. Irvine AD, McLean WHI: Breaking the (un)sound barrier. J Invest Dermatol 2006, 126, 1200-1292.
20. Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, Motala C, Ortega Martell JA, Platts-Mills TA, Ring J, Thien F, Van Cauwenberge P, Williams HC: Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organisation, October 2003. J Allergy Clin Immunol 2004, 113, 832-836.
21. Leung DYM, Bieber T: Atopic dermatitis. Lancet 2003, 361, 151-160.
22. Leung DYM, Boguniewicz M, Howell M, Nomura I, Hamid Q: New insights in atopic dermatitis. J Clin Invest 2004, 113, 651-657.
23. Leung DYM, Nelson HS, Szefler SJ, Busse WW: The editors' choice: Autoreactivity in atopic dermatitis-induced by skin fungi? J Allergy Clin Immunol 2005, 115, 895-896.
24. Marenholz I, Nickel R, Rüschendorf F, Schulz F, Esparza-Gordillo J, Kersche T, Grüber C, Lau S, Worm M, Kei Tl, Kurek M, Zaluga E, Wahn U, Lee YA: Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol 2006, 118, 866-871.
25. Novembre E, Cianferoni A, Lombardi E, Bernardini R, Pucci N, Vierucci A: Natural history of "intrinsic" atopic dermatitis. Allergy 2001, 56, 452-453.
26. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DYM: Endogenous antimicrobial peptides and skin infections in atopic dermatitis. New England J Medicine 2002, 347, 1151-1160.
27. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, Leung DY, Boguniewicz M: Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006, 38, 441-446.
28. Ravenscroft JC, Layton AM, Eady EA, Murtagh MS, Coates P, Walker M, Cove JH: Short-term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema. Br J Dermatol 2003, 148, 1010-1017.
29. van Reijsen FC, Bruijnzeel-Koomen CAFM, Kalthoff FS: Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol 1992, 90, 184-192.
30. Reitamo S, Wollenberg A, Schöpf E, Perrot JL, Marks R, Ruzicka T, Christophers E, Kapp A, Lahfa M, Rubins A, Jablonska S, Rustin M: Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. Arch Dermatol 2000, 136, 999-1006.
31. Roll A, Cozzio A, Fischer B, Schmid-Grendelmeier P: Microbial colonization and atopic dermatitis. Curr Opin Allergy Immunol 2004, 4, 373-378.
32. Sager N, Feldmann A, Schilling G, Kreitsch P, Neumann C: House dust mite-specific T cells in the skin of subjects with atopic dermatitis: frequency and lymphokine profile in the allergen patch test. J Allergy Clin Immunol 1992, 89, 801-810.
33. Schmid-Grendelmeier P, Simon D, Simon HU, Akdis CA, Wuthrich B: Epidemiology, clinical features, and immunology of the "intrinsic" (non-IgE mediated) type of atopic dermatitis (constitutional dermatitis). Allergy 2001, 56, 841-849.
34. Schmid-Grendelmeier P, Fischer B, Wüthrich B: IgE to Malassezia furfur/M. sympodialis. ACI International 2002, 14, 140-142.
35. Schmid-Grendelmeier P, Flückiger S, Disch R, Trautmann A, Wüthrich B, Blaser K, Scheynius A, Crameri R: IgE-mediated and T cell-mediated autoimmunity against manganese superoxide dismutase in atopic dermatitis. J Allergy Clin Immunol 2005, 115, 1068-1075.
36. Schmid-Grendelmeier P, Scheynius A, Crameri R: The role of sensitization to Malassezia sympodialis in atopic eczema. In: Crameri R (Ed): Allergy and Asthma in the Modern Society: The Scientific Approach. Chem Immunol Allergy 2006, 91, 98-109.
37. Senti G, Steinmann LS, Fischer B, Kurmann R, Storni T, Johansen P, Schmid-Grendelmeier P, Wüthrich B, Kündig TM: Antimicrobial silk clothing in the treatment of atopic dermatitis proves comparable to topical corticosteroid treatment. Dermatology 2006, 213, 228-233.
38. Sicherer SH, Sampson HA: Food hypersensitivity and atopic dermatitis: pathophysiology, epidemiology, diagnosis, and management. J Allergy Clin Immunol 1999, 104, 114-122.
39. Simon D, Lübbe J, Wüthrich B, Wiesner A, Weber MM, Lafitte E, Anliker MD, Schöni MH, Braathen LR, Schmid-Grendelmeier P, Gilgen Bobalj N, Schneider D: Benefits from use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice. Dermatology 2006, 213, 313-318.
40. Svejgaard E, Larsen PO, Deleuran M, Ternowitz T, Roed-Petersen J, Nilsson J: Treatment of head and neck dermatitis comparing itraconazole 200 mg and 400 mg daily for 1 week with placebo. J Eur Acad Dermatol Venereol 2004, 18, 445-449.
41. Warner JO for the ETAC Study Group: A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up. J Allergy Clin Immunol 2001, 108, 929-937.
42. Werfel T, Breuer K: Role of food allergy in atopic dermatitis. Curr Opin Allergy Clin Immunol 2004, 4, 379-385.
43. Werfel T, Breuer K, Rueff F, Przybilla B, Worm M, Grewe M, Ruzicka T, Brehler R, Wolf H, Schnitker J, Kapp A: Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multicentre, randomized, dose-response study. Allergy 2006, 61, 202-205.
44. Williams HC, Wüthrich B: The natural history of atopic dermatitis. In: Williams HC (Ed): Atopic Dermatitis. The Epidemiology, Causes and Prevention of Atopic Eczema, 41-59. Cambridge University Press 2000.
45. Wollenberg A, Bieber T: Atopic dermatitis: from the genes to skin lesions. Allergy 2000, 55, 205-213.
46. Wüthrich B: Neurodermitis atopica sive constitutionalis. A pathogenetic model from the view of an allergologist [Neurodermitis atopica sive constitutionalis. Ein pathogenetisches Modell aus der Sicht des Allergologen]. Akt Dermatol 1983, 9, 1-7.
47. Wüthrich B: Atopic dermatitis flare provoked by inhalant allergens. Dermatologica 189, 178, 51-53.
48. Wüthrich B: Clinical aspects, epidemiology, and prognosis of atopic dermatitis. Ann Allergy Asthma Immunol 1999, 83, 464-470.
49. Wüthrich B: Contact urticaria and protein contact dermatitis to food. In: Marone G (Ed): Clinical Immunology and Allergy in Medicine, 175-182. JGC Editions, Naples 2003.
50. Wüthrich B: Natural history of atopic eczema. Chapter 14. In: Ring J, Przybilla B, Ruzicka T (Eds): Handbook of Atopic Dermatitis. 2nd Edition. Springer-Verlag, Berlin-Heidelberg-New York 2006, 150-156.
51. Wüthrich B, Schmid-Grendelmeier P: Natural course of AEDS. Allergy 2002, 57, 267-268.
52. Wüthrich B, Schmid-Grendelmeier P: Definition and diagnosis of intrinsic vs extrinsic atopic dermatitis. In: Bieber T, Leung DYM (Eds): Impact of Atopic Dermatitis, 1-20. Marcel Dekker, New York-Basel 2002.
53. Wüthrich B, Schmid-Grendelmeier P: The atopic eczema/dermatitis syndrome. Epidemiology, natural course, and immunology of the IgE-associated ("extrinsic") and the nonallergic ("intrinsic") AEDS. J Investig Allergol Clin Immunol 2003, 13, 1-5.
54. Wüthrich B, Baumann E, Fries RA, Schnyder UW: Total and specifi c IgE (RAST) in atopic twins. Clin Allergy 1981, 11, 147-154.
55. Wüthrich B, Roll A, Fischer B, Senti G, Schmid-Grendelmeier P: Aktuelles zur atopischen Dermatitis (Neurodermitis). Allergologie 2005, 28, 92-104.